Q2 FY2026 EarningsQ2 FY26 missed consensus estimates significantly across all profitability metrics: revenue was $44.2M vs. $46.1M expected, and GAAP EPS was -$0.23 vs. $0.02 expected. Results were severely impacted by a $3.3M revenue headwind from the January 2026 voluntary pellet recall and a $5.1M legal settlement charge. Despite a 21% YoY growth in dietary supplements, the core pellet procedure business saw volumes contract, leading to a net loss of $7.4M compared to an expected net income of $0.9M.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: biote Corp.(BTMD) the Revenue is 44.23 M (-9.48%), Miss estimate;the EBIT is -3.508 M (-132.6%), Miss estimate;the EPS is -0.23 (-330%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.04B9.48%
0.05B5.69%
-0.00B3.79%
EBITMiss expectations
-0.00B132.59%
0.00B56.69%
-0.01B75.90%
EPSMiss expectations
-0.23330.00%
0.02575.00%
-0.2550255.00%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf